Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Cholesterol jab: why gene silencing drugs may work better than current treatments

By Aristides Tagalakis, Reader in Gene Delivery and Nanomedicine, Edge Hill University
Share this article
The NHS has very recently approved a new cholesterol-lowering jab which will be offered to 300,000 people over the next three years.

The drug – inclisiran – will be administered twice a year as an injection. It will mainly be prescribed to patients who suffer with a genetic condition that leads to high cholesterol, those who have already suffered a heart attack or stroke, or those who haven’t…

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter